EP Patent

EP3981399A4 — SOLID TABLET FOR ORAL USE COMPRISING BRUTON'S TYROSINE KINASE INHIBITOR AND METHOD OF PREPARING IT

Assigned to BeOne Medicines I GmbH · Expires 2023-05-31 · 3y expired

What this patent protects

Patent listed against Brukinsa.

Drugs covered by this patent

Patent Metadata

Patent number
EP3981399A4
Jurisdiction
EP
Classification
—
Expires
2023-05-31
Drug substance claim
No
Drug product claim
No
Assignee
BeOne Medicines I GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.